Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 58602-703

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Cetirizine Hydrochloride And Pseudoephedrine Hydrochloride (NDC 58602-703). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel -5 mg/120 mg (12 X 2) Blister Carton (Cetirizine Pseudo Fig1)

Packaging label for Cetirizine Hydrochloride and Pseudoephedrine Hydrochloride Extended-Release Tablets, USP 5 mg/120 mg by Aurohealth LLC. The label indicates 24 film-coated tablets for oral use, providing antihistamine and nasal decongestant effects for allergy and sinus relief. It includes Drug Facts detailing active ingredients, uses, warnings, directions, and inactive ingredients. The label features branding and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.